Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-03-000166
Filing Date
2003-03-31
Accepted
2003-03-31 14:55:20
Documents
4
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2106628z10-k.htm 10-K 502253
3 EX-23.1 a2106628zex-23_1.htm EX-23.1 1840
4 EX-23.2 a2106628zex-23_2.htm EX-23.2 4959
5 EX-99.1 a2106628zex-99_1.htm EX-99.1 3220
  Complete submission text file 0000912057-03-000166.txt   514160
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12493 | Film No.: 03629545
SIC: 2836 Biological Products, (No Diagnostic Substances)